(Q57904446)
Statements
A phase 1/2 study of lenalidomide with low-dose oral cyclophosphamide and low-dose dexamethasone (RdC) in AL amyloidosis (English)
0 references
18 April 2012
0 references
119
0 references
23
0 references
5384-5390
0 references